Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Airway Dendritic Cells in Allergic Asthma
NCT04619017Phase 1Unknown
- Start
- Oct 2021
- Primary completion
- Apr 2023
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial. Primary endpoints: Dendritic cell number and phenotype at 18 months, Dendritic cell function at 18 months and 3 more. Status: unknown.
Beyond the preview
Go deeper on NCT04619017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04619017.